Goldman Sachs’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.1M | Buy |
1,195,516
+187,816
| +19% | +$3.01M | ﹤0.01% | 1804 |
|
|
2025
Q1 | $17.2M | Buy |
1,007,700
+329,354
| +49% | +$5.63M | ﹤0.01% | 1810 |
|
|
2024
Q4 | $16.8M | Buy |
678,346
+156,673
| +30% | +$3.88M | ﹤0.01% | 1928 |
|
|
2024
Q3 | $14.9M | Buy |
521,673
+109,755
| +27% | +$3.13M | ﹤0.01% | 1942 |
|
|
2024
Q2 | $10.9M | Buy |
411,918
+62,741
| +18% | +$1.66M | ﹤0.01% | 2036 |
|
|
2024
Q1 | $11.3M | Sell |
349,177
-108,954
| -24% | -$3.52M | ﹤0.01% | 1961 |
|
|
2023
Q4 | $19.3M | Sell |
458,131
-52,309
| -10% | -$2.2M | ﹤0.01% | 1594 |
|
|
2023
Q3 | $19.6M | Buy |
510,440
+185,194
| +57% | +$7.11M | ﹤0.01% | 1516 |
|
|
2023
Q2 | $6.17M | Sell |
325,246
-115,612
| -26% | -$2.19M | ﹤0.01% | 2412 |
|
|
2023
Q1 | $6.84M | Buy |
440,858
+69,610
| +19% | +$1.08M | ﹤0.01% | 2293 |
|
|
2022
Q4 | $6.59M | Buy |
371,248
+300,179
| +422% | +$5.33M | ﹤0.01% | 2429 |
|
|
2022
Q3 | $396K | Sell |
71,069
-173,883
| -71% | -$969K | ﹤0.01% | 4387 |
|
|
2022
Q2 | $955K | Sell |
244,952
-110,742
| -31% | -$432K | ﹤0.01% | 3973 |
|
|
2022
Q1 | $1.96M | Buy |
355,694
+61,845
| +21% | +$341K | ﹤0.01% | 3604 |
|
|
2021
Q4 | $2.5M | Sell |
293,849
-165,124
| -36% | -$1.41M | ﹤0.01% | 3332 |
|
|
2021
Q3 | $3.99M | Buy |
458,973
+253,239
| +123% | +$2.2M | ﹤0.01% | 2944 |
|
|
2021
Q2 | $2.18M | Sell |
205,734
-840,647
| -80% | -$8.89M | ﹤0.01% | 3445 |
|
|
2021
Q1 | $16.8M | Buy |
1,046,381
+259,626
| +33% | +$4.16M | ﹤0.01% | 1801 |
|
|
2020
Q4 | $36.3M | Buy |
786,755
+663,454
| +538% | +$30.6M | 0.01% | 1167 |
|
|
2020
Q3 | $4.34M | Sell |
123,301
-27,236
| -18% | -$958K | ﹤0.01% | 2477 |
|
|
2020
Q2 | $3.67M | Buy |
150,537
+76,695
| +104% | +$1.87M | ﹤0.01% | 2514 |
|
|
2020
Q1 | $1.15M | Buy |
+73,842
| New | +$1.15M | ﹤0.01% | 3044 |
|